Altimmune Net Income Per Share from 2010 to 2026
| ALT Stock | USD 4.87 0.05 1.02% |
Net Loss | First Reported 2010-12-31 | Previous Quarter (1.20) | Current Value (1.27) | Quarterly Volatility 211.14523154 |
Check Altimmune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Altimmune's main balance sheet or income statement drivers, such as Interest Expense of 7.7 K, Selling General Administrative of 14 M or Total Revenue of 17.1 K, as well as many indicators such as Price To Sales Ratio of 24.2 K, Dividend Yield of 23.4 or PTB Ratio of 3.92. Altimmune financial statements analysis is a perfect complement when working with Altimmune Valuation or Volatility modules.
Altimmune | Net Income Per Share | Build AI portfolio with Altimmune Stock |
The evolution of Net Income Per Share for Altimmune provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Altimmune compares to historical norms and industry peers.
Latest Altimmune's Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of Altimmune over the last few years. It is Altimmune's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Altimmune's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Altimmune Net Income Per Share Regression Statistics
| Arithmetic Mean | 30.83 | |
| Coefficient Of Variation | 684.86 | |
| Mean Deviation | 95.37 | |
| Median | (1.91) | |
| Standard Deviation | 211.15 | |
| Sample Variance | 44,582 | |
| Range | 950 | |
| R-Value | (0.04) | |
| Mean Square Error | 47,460 | |
| R-Squared | 0 | |
| Significance | 0.87 | |
| Slope | (1.86) | |
| Total Sum of Squares | 713,317 |
Altimmune Net Income Per Share History
About Altimmune Financial Statements
Altimmune shareholders use historical fundamental indicators, such as Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Altimmune investors may analyze each financial statement separately, they are all interrelated. The changes in Altimmune's assets and liabilities, for example, are also reflected in the revenues and expenses on on Altimmune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | (1.20) | (1.27) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.